Phase Forward to Participate in Six Industry Events in November

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in six industry events this month including the ChinaTrials Global Clinical Development Summit and CBI's 5th Forum on Patient Reported Outcomes (PRO).

At the ChinaTrials Global Clinical Development Summit, November 8-10, in Beijing, China, Phase Forward (booth # 22) Regional Director and General Manager Jon Carrano will moderate a panel on EDC in China. Session details are as follows:

Who: Jon Carrano, Ph.D., Regional Director and General Manager, Phase Forward (Moderator) What: "Electronic Data Capture and Clinical Data Management in China" When: Tuesday, November 10, 10:10-11:10 a.m. local time

At CBI's 5th Forum on Patient Reported Outcomes, November 17-18, in Philadelphia, Pa., Phase Forward will exhibit its late phase solutions and Vice President and Conference Chair Scott Dixon will participate in the following session:

Who: Scott Dixon, Vice President, Outcome Logix Group, Phase Forward (Moderator) What: "Recall Period -- What Works and What Doesn't?" When: Wednesday, November 18, 9:00-9:45 a.m. Eastern time

As Conference Chair, Mr. Dixon will also deliver opening remarks on the first day of the conference at 1:15 p.m. and on the second day at 8:00 a.m.

In addition to its speaking engagements, Phase Forward will participate in the following conferences throughout the month of November:

What: 8th Annual Partnerships in Clinical Trials When: November 4-5, Rotterdam, The Netherlands Where: Booth # 71

What: American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS) When: November 8-12, Los Angeles, Calif. Where: Booth # 702

What: CDISC Interchange North America When: November 9-13, Baltimore, Md. Where: Booth # 7

What: 2nd DIA Conference on Signal Detection and Data Mining When: November 16-18, New York, N.Y.

Members of the media interested in speaking with Phase Forward should contact Maria Sumner at +44 1628 640743 or maria.sumner@phaseforward.com or Meghan Locke at 781-672-3147 or mlocke@chenpr.com.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

SOURCE: Phase Forward

Phase Forward 
Elaine Maynard, 781-902-4371 
elaine.maynard@phaseforward.com 
or 
CHEN PR, Inc. 
Meghan Locke, 781-672-3147 
mlocke@chenpr.com

Related terms: beijing, cancer, china, clinical, conference, fda, healthcare, knowledge management, local, nasdaq, new york, north america, pharmaceuticals, president, products, recall, research, trial